According to a new report, published by KBV research, The Global Dietary Supplement Contract Manufacturing Market size is expected to reach $131.5 billion by 2031, rising at a market growth of 12.3% CAGR during the forecast period.
The dietary supplement contract manufacturing market has grown significantly in recent years due to growing consumer awareness of health and wellness, a rise in the need for individualized nutrition plans, and improvements in production technologies. Contract manufacturing offers brands and retailers the flexibility to outsource the production of dietary supplements to specialized manufacturers, allowing them to focus on branding, marketing, and distribution.
The Proteins & Amino Acid Supplements segment led the Global Dietary Supplement Contract Manufacturing Market by Product Type in 2023; thereby, achieving a market value of $52.6 billion by 2031. Protein supplements are widely recognized for supporting muscle building and improving exercise performance. Protein shakes, bars, and powders are popular sources of high-quality protein for bodybuilders and athletes to fulfill their increased needs and maximize muscle recovery following intensive workouts. Hence, these factors will boost the demand in the segment.
The Tablets segment is growing at a CAGR of 11.4 % during the forecast period. Tablets are one of the most convenient and accessible dosage forms for dietary supplements. Daily supplementation is a popular option for customers who prefer the ease of use and familiarity of tablets because they are simple to take, store, and transport. Hence, these aspects can lead to enhanced demand in the segment.
Full Report: https://www.kbvresearch.com/dietary-supplement-contract-manufacturing-market/
The North America region dominated the Global Dietary Supplement Contract Manufacturing Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $43.4 billion by 2031. The Europe region is anticipated to grow at a CAGR of 11.9% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 13.1% during (2024 - 2031).
By Product Type
By Dosage Form
By Geography
Unique Offerings 
